Stem cells in tumor angiogenesis (Q37806811)

23 August 2017

title

Stem cells in tumor angiogenesis (English)

1 reference

23 August 2017

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21047516

19 August 2024

author name string

Shentong Fang

1

1 reference

23 August 2017

Petri Salven

2

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21047516

19 August 2024

publication date

1 November 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0022282810004037?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

https://api.elsevier.com/content/article/PII:S0022282810004037?httpAccept=text/plain

19 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Journal of Molecular and Cellular Cardiology

19 August 2024

published in

1 reference

23 August 2017

volume

50

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

290-295

1 reference

Angiogenesis in health and disease

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Angiogenesis in life, disease and medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Tumor angiogenesis: therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Refractoriness to antivascular endothelial growth factor treatment: role of myeloid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

The role of myeloid cells in the promotion of tumour angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Isolation of putative progenitor endothelial cells for angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Tumor response to radiotherapy regulated by endothelial cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Minor contribution of bone marrow-derived endothelial progenitors to the vascularization of murine gliomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Circulating Vascular Progenitor Cells Do Not Contribute to Compensatory Lung Growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Bone marrow-derived cells do not incorporate into the adult growing vasculature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Bone marrow-derived lin(-)c-kit( )Sca-1 stem cells do not contribute to vasculogenesis in Lewis lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Contribution of bone marrow–derived endothelial cells to human tumor vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Bone marrow-derived cells do not repair endothelium in a mouse model of chronic endothelial cell dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Angiogenic monocytes: another colorful blow to endothelial progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Circulating monocytes expressing CD31: implications for acute and chronic angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Blood monocytes mimic endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Human CD34 AC133 VEGFR-2 cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Microarray-based characterization of a colony assay used to investigate endothelial progenitor cells and relevance to endothelial function in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Defining human endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Role of bone marrow-derived cells in tumor angiogenesis and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Macrophages and tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Expansion of myeloid immune suppressor Gr CD11b cells in tumor-bearing host directly promotes tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Myeloid-derived suppressor cells: linking inflammation and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Altered recognition of antigen is a mechanism of CD8 T cell tolerance in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Myeloid-derived suppressor cell role in tumor-related inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8 T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Role of myeloid cells in tumor angiogenesis and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1 CD11b myeloid cells that promote metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Neutrophils: key mediators of tumour angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Tumor-associated tissue eosinophilia in nasopharyngeal carcinoma. A pathologic study of 422 primary and 138 metastatic tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3 endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

The role of mast cells in tumour angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Mast-cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Differential release of mast cell mediators and the pathogenesis of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

DC subsets in positive and negative regulation of immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Tumors stimulate platelet delivery of angiogenic factors in vivo: an unexpected benefit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Lysophospholipid receptors: signaling and biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Inflammation induces hemorrhage in thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Analysis of mural cell recruitment to tumor vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Mural cell associated VEGF is required for organotypic vessel formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Endothelial-mural cell signaling in vascular development and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

PDGFRbeta perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Mesenchymal stem cells in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Multilineage potential of adult human mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Marrow stromal cells as stem cells for nonhematopoietic tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Immunomodulatory properties of mesenchymal stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Endothelial cells and VEGF in vascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Vascular development: from precursor cells to branched arterial and venous networks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

VEGFR-3 and CD133 identify a population of CD34 lymphatic/vascular endothelial precursor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Endothelial progenitor cells, angioblasts, and angiogenesis--old terms reconsidered from a current perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Identification of stem cells in small intestine and colon by marker gene Lgr5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Endothelial outgrowth cells are not derived from CD133 cells or CD45 hematopoietic precursors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

A role for hematopoietic stem cells in promoting angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Enhanced expression of vascular endothelial growth factor in metastatic melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Endothelial cell diversity revealed by global expression profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

What is the role of endothelial cells in angiogenesis?

7 January 2021

7

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process?

19 August 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis

19 August 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Tumor infiltrating cells in human cancer. On the possible role of CD16 macrophages in antitumor cytotoxicity

19 August 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma

19 August 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density

19 August 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis

19 August 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation

19 August 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

A mitogenic factor for transformed fibroblasts from human platelets

19 August 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor

19 August 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors

19 August 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance

19 August 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.10.024

19 August 2024

Identifiers

1 reference

23 August 2017

1 reference